Stuart E. Smith

1.2k total citations
18 papers, 1.0k citations indexed

About

Stuart E. Smith is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Stuart E. Smith has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 4 papers in Psychiatry and Mental health. Recurrent topics in Stuart E. Smith's work include Neuroscience and Neuropharmacology Research (13 papers), Ion channel regulation and function (4 papers) and Epilepsy research and treatment (4 papers). Stuart E. Smith is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Ion channel regulation and function (4 papers) and Epilepsy research and treatment (4 papers). Stuart E. Smith collaborates with scholars based in United Kingdom, Denmark and Mexico. Stuart E. Smith's co-authors include Brian S. Meldrum, Astrid G. Chapman, N. Dürmüller, Ania Koziell, Robert H. Coker, D. Lekieffre, Peter Sowinski, Jerzy Krupiński, A. Jacqueline Hunter and AA Parsons and has published in prestigious journals such as The Journal of Physiology, Stroke and Neuroscience.

In The Last Decade

Stuart E. Smith

18 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart E. Smith United Kingdom 13 705 429 249 156 113 18 1.0k
Roger Marrannes Belgium 15 437 0.6× 349 0.8× 193 0.8× 82 0.5× 86 0.8× 34 1.0k
Gilbert Clincke Belgium 17 389 0.6× 317 0.7× 125 0.5× 93 0.6× 105 0.9× 41 873
Mary C. Evans United Kingdom 14 1.0k 1.4× 624 1.5× 234 0.9× 207 1.3× 123 1.1× 18 1.4k
Susan Gerhardt Switzerland 15 591 0.8× 279 0.7× 118 0.5× 164 1.1× 82 0.7× 24 833
Francesca Spadoni Italy 15 661 0.9× 482 1.1× 315 1.3× 35 0.2× 152 1.3× 21 979
Marı́a Sitges Mexico 19 528 0.7× 354 0.8× 252 1.0× 74 0.5× 38 0.3× 33 809
Taisija de Gubareff United States 17 758 1.1× 631 1.5× 164 0.7× 67 0.4× 95 0.8× 20 1.3k
M. Duff Davis United States 21 666 0.9× 615 1.4× 106 0.4× 38 0.2× 55 0.5× 51 1.2k
Brian Ault United States 22 1.1k 1.6× 739 1.7× 201 0.8× 67 0.4× 73 0.6× 43 1.5k
Artur W. Wamil United States 16 429 0.6× 245 0.6× 498 2.0× 45 0.3× 84 0.7× 24 1.0k

Countries citing papers authored by Stuart E. Smith

Since Specialization
Citations

This map shows the geographic impact of Stuart E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart E. Smith more than expected).

Fields of papers citing papers by Stuart E. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart E. Smith. The network helps show where Stuart E. Smith may publish in the future.

Co-authorship network of co-authors of Stuart E. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart E. Smith. A scholar is included among the top collaborators of Stuart E. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart E. Smith. Stuart E. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Strong, Anthony J., Stuart E. Smith, Brian S. Meldrum, et al.. (2000). Factors Influencing the Frequency of Fluorescence Transients as Markers of Peri-Infarct Depolarizations in Focal Cerebral Ischemia. Stroke. 31(1). 214–222. 78 indexed citations
2.
Bertaux, Fabien, William H Colledge, Stuart E. Smith, et al.. (1997). Normotensive blood pressure in mice with a disrupted renin Ren-1d gene. Transgenic Research. 6(3). 191–196. 9 indexed citations
3.
Smith, Stuart E., H. Courtney Hodges, Piotr Sowiński, et al.. (1997). Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat. Neuroscience. 77(4). 1123–1135. 50 indexed citations
4.
Smith, Stuart E., et al.. (1995). The γ-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy. European Journal of Pharmacology. 273(3). 259–265. 39 indexed citations
5.
Smith, Stuart E. & Brian S. Meldrum. (1995). Cerebroprotective Effect of Lamotrigine After Focal Ischemia in Rats. Stroke. 26(1). 117–122. 122 indexed citations
6.
Smith, Stuart E. & Astrid G. Chapman. (1993). Acute and chronic anticonvulsant effects of d(−)CPPene in genetically epilepsy-prone rats. Epilepsy Research. 15(3). 193–199. 7 indexed citations
7.
Smith, Stuart E., D. Lekieffre, Peter Sowinski, & Brian S. Meldrum. (1993). Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat. Neuroreport. 4(12). 1339–1342. 49 indexed citations
8.
Smith, Stuart E., et al.. (1993). Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat. Epilepsy Research. 15(2). 101–111. 39 indexed citations
9.
Dürmüller, N., Stuart E. Smith, & Brian S. Meldrum. (1993). Proconvulsant and anticonvulsant effects of Evans blue dye in rodents. Neuroreport. 4(6). 683–686. 4 indexed citations
10.
Smith, Stuart E. & Brian S. Meldrum. (1992). The protein kinase C activators, phorbol 12-myristate,13-acetate and phorbol 12,13-dibutyrate, are convulsant in the pico-nanomolar range in mice. European Journal of Pharmacology. 213(1). 133–135. 15 indexed citations
11.
Smith, Stuart E. & Brian S. Meldrum. (1992). The glycine-site NMDA receptor antagonist, R-(+)− cis-β-methyl-3-amino-1-hydroxypyrrolid-2-one, L-687, 414 is anticonvulsant in baboons. European Journal of Pharmacology. 211(1). 109–111. 33 indexed citations
12.
Smith, Stuart E. & Brian S. Meldrum. (1992). Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat.. Stroke. 23(6). 861–864. 122 indexed citations
13.
Smith, Stuart E., N. Dürmüller, & Brian S. Meldrum. (1991). The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. European Journal of Pharmacology. 201(2-3). 179–183. 151 indexed citations
14.
Chapman, Astrid G., Stuart E. Smith, & Brian S. Meldrum. (1991). The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Research. 9(2). 92–96. 175 indexed citations
15.
Smith, Stuart E. & N. Dürmüller. (1990). Inositolhexakisphosphate is convulsant in mice and rats in the nanomolar range. European Journal of Pharmacology. 191(3). 337–343. 10 indexed citations
16.
Smith, Stuart E. & Brian S. Meldrum. (1990). Receptor site specificity for the acute effects of β-N-methylamino-alanine in mice. European Journal of Pharmacology. 187(1). 131–134. 44 indexed citations
17.
Coker, Robert H., et al.. (1984). Does the sympathetic nervous system influence sinus arrhythmia in man? Evidence from combined autonomic blockade.. The Journal of Physiology. 356(1). 459–464. 60 indexed citations
18.
Lin, Chu Yuan & Stuart E. Smith. (1976). The effect of halofenate and clofibrate on aggregation and release of serotonin by human platelets. Life Sciences. 18(6). 563–568. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026